StemGenex Ordered to Pay More Than $3.5 Million in Class-Action Lawsuit

San Diego, Calif.-based StemGenex, a stem-cell clinic, has been ordered to pay more than $3.5 million in damages in a class-action settlement.

The complaint, filed in U.S. District Court for the Southern District of California, alleged that the clinic offered stem-cell treatments, claiming that the therapies could cure incurable diseases and treat disabilities.

The plaintiffs argued that the company misled them with its claims and that the treatments were shown to be ineffective.

The FDA issued a warning letter to the company in October 2018. StemGenex filed for bankruptcy in 2019.